undifferentiated gut symptons...• inflammatory bowel disease during treatment and as marker •...
TRANSCRIPT
Undifferentiated Gut Symptoms
Prof Tony Catto-Smith
Director of Gastroenterology
Lady Cilento Children’s Hospital
Undifferentiated gut symptoms
– The screaming baby and PPI’s
– How to dose with PPI’s
– Abdominal pain, diarrhoea
and lactose intolerance
– Treating Dientamoeba – or not?
– Coeliac disease, serology and HLA
testing
– Abdominal pain, rectal bleeding,
diarrhoea and calprotectin
The screaming baby
• ‘A vicious circle is set in motion; the
screaming infant, the harried mother and
the helpless father all fervently wishing
they were someone or somewhere else.
The parental anxiety reinforces the
symptoms and by the time of consultation
the physician is faced by an array of
distraught and dishevelled human beings.’
• Des Gurry after Ziai
0
1
2
3
4
2 3 4 5 6 7 8 9 10 11 12
Age in weeks
Hou
rs o
f cry
ing
/ 24
hrs
Crying in infancy
Median
Upper quartile
Lower quartile
From: TB Brazelton (1990) Infant Mental Health Journal 11:349-356
Drug therapy
• Prokinetics
– Cisapride
• Antiacid drugs
– H2 receptor antagonists
(ranitidine)
– PPI’s
The screaming baby and PPI’s
• PPI’s ineffective
Gieruszczak-Bialek J Pediatr 2015
No Effect of Proton Pump Inhibitors on Crying and Irritability in Infants: Systematic Review of Randomized Controlled Trials
How to dose PPI’s
– Proton Pump Inhibitors
broken down in acid -
best absorbed from alkaline
intestine (enteric coating)
– T ½ 1.5hr
– Tmax 1-3hr
– Concentrated in acid
compartments (parietal cell)
– HAS TO BE ACTIVELY
SECRETING ACID
• Covalently bind to proton pump
(H+, K + ATPase) in canaliculus
• Acid inhibition lasts up to 24hr
• Takes 18hr for synthesis of new
proton pumps
Katzung 2009
How to dose PPI’s • Bioavailability
– decreased 50% by food
– need to be given on empty stomach
– In fasting state only 10% proton
pumps are actively secreting acid and
susceptible to inhibition
– Going to bed dosing not effective
• Up to 3-4 days of daily medication before
full acid inhibition potential is achieved
• IV PPI same principles but short half life
and acid secretion returns in hours – IV
has to be given as continuous secretion or
repeated boluses
• PPIs best taken approx 1hr before
a meal (usually breakfast) so peak
serum concentration coincides
with maximal activity of proton
pump secretion
Table 1 Reported associations with PPI use and adverse events
Kia, L. & Kahrilas, P. J. (2016) Risks associated with chronic PPI use — signal or noise? Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2016.44
Stomach acid, PPI’s and C difficile
• Stomach acid is a microbial disinfectant
• Strong evolutionary biological correlation between gastric acidity and “bacterial risk” of diet (eg carnivores vs herbivores) Beasley PlosOne 2015
• Less acid neonatal stomach may allow easier microbial entry to gut – a good thing
• Long term PPI use – Has variable effects on
bacterial diversity
– Specifically influences 3 bacterial strains which have metabolic products which:-
– Upregulate bacterial genes associated with epithelial invasion Freedberg Gastroenterology 2015
Abdo pain, diarrhoea and lactose
intolerance • 9yr old boy of
Vietnamese background
with abdo pain and
diarrhoea whenever he
drinks milk – well in
himself
• Neither parent drinks
milk
Genetic variation in Primary Lactase Deficiency
• POPULATION ADULT DECLINE IN LACTASE ACTIVITY (%)
• Asian 90 - 100
• African Black 85 - 100
• Mediterranean 60 - 85
• Native American 50 - 95
• American Black 45 - 80
• Mexican American 40 - 75
• Northern European 5 - 15
• American Caucasian 10 - 25
Simoons FJ. The geographical hypothesis and lactose malabsorption: a weighing of the evidence. Am J Dig Dis 1978;23:963
BEFORE post-weaning decline, lactase activity
can be lost by:
• Infection
• Malnutrition
• Inflammatory processes (eg Crohn’s)
• Loss of luminal nutrients
• Small bowel bacterial overgrowth
=Secondary Lactase Deficiency
Treating Dientamoeba – or not?
• 7 yr old boy – abdo pain
and 4 days of loose
stools
• PCR showed
Dientamoeba fragilis
• Dientamoeba linked to
intermittent diarrhoea, abdo
pain, nausea, anorexia, malaise,
fatigue, eosinophilia
• 2013 – detection changed from
microscopy to multiplex PCR
(Giardia lamblia,
Cryptosporidium spp, Entamoeba
histolytica, Dientamoeba fragilis,
Blastocystis spp)
Bowen 2016
Roser 2014
Garcia 2016
Treating Dientamoeba – or not?
• Significant concerns regarding D
fragilis and Blastocystis – role as
putative GI pathogens
controversial and possibly
unproven.
• Both may be colonising flora –
prevalence rates about 17% esp
in children under age 10yr – 2nd
peak at 30-40 yr of age
• Best evidence in children – – double blind randomised
controlled trial showed no
difference in symptoms between
treatment and placebo for
dientamoebiasis
– though did partially eradicate
(62% at 2 wk, 25% 8wk)
– n=96, metronidazole – Denmark
Bowen MJA 2016
Garcia Clin Infect Dis 2016
Dientamoeba and Blastocystis
recommendations from Australian Society of Infectious Diseases and
Royal College of Pathologists of Australasia
• Putative roles of Dientamoeba
and Blastocystis controversial and
unproven
• Testing leads to inappropriate
medical consultations,
unnecessary use of
antimicrobials, anxiety for
families
• ASID and RCPA recommend to practitioners
– Do not request stool pathogen assessment (including
multiplex faecal PCR) on formed stool samples;
– do not request specific testing for D.
fragilis or Blastocystis spp.;
– should consider the markedly increased sensitivity with
unclear significance in their clinical interpretation of
pathology laboratory reports of detection of these
parasites;
– adhere to comments appended to the laboratory report
regarding the significance of D. fragilis and Blastocystis spp.
and avoid specific treatment and further testing;
– discuss with a paediatric or adult infectious diseases
specialist or medical microbiologist, if clarification is
required.
• Recommends that laboratories do not include D fragilis and
Blastocystis spp within enteric multiplex testing. If still tested
and reported, recommend including a cautionary note.
http://www.rcpa.edu.au/Library/College-Policies/Guidelines/Faecal-pathogen-testing-by-PCR.aspx
Coeliac disease, serology and HLA testing
• 4 yr old – loose stools for 1 yr
• Coeliac testing
– IgA tissue translutaminase 6 (NR<7)
– IgG deamidated antigliadin 5 (NR<7)
– Total IgA 0.9 (normal range)
– HLA DQ2 present
– HLA DQ8 not present
• What does this mean?
• Coeliac prevalence approx 1/80
• HLA DQ2/8 status of coeliacs
– 90% coeliacs have HLA DQ2
– 5% HLA DQ8, 5% variations on HLA DQ2
• HLA DQ2/8 genes in general population
– 65% of first degree relatives of CD
– 30-40% Western population (56% Vic)
• Predictive value of HLA testing
– PPV 3.4% general population (CD prev 1%)
– 28% high risk population (CD prev 10%)
– Negative predictive value >99%
• HLA DQ2/8 testing in coeliac
– 10 fold increase from 2003-2014 (2,826-32,039 services)
– Concern regarding
• HLA testing in inappropriate clinical situations
• Overly complicated/ambiguous HLA results
• Inappropriate medical decisions based on results
(eg starting gluten free diets)
Tye-Din Int Med J 2015
Blood tests for coeliac disease
• CD Serology
– First line in symptomatic children
• TTG (IgA), DAG (IgG)
• High PPV (>90%) pop prev 1%
– HLA DQ2/8 if Asymptomatic at risk
• HLA typing – if positive→
• Serology (absence of HLA excludes
CD)
• HLA negative EXCLUDES CD
Appropriate use of HLA typing – CD serology or biopsies inconclusive
or equivocal HLA useful to triage
(lymphocytic duodenitis, inadequate
sampling or gluten,
immunosuppressants)
– Failure to improve on gluten free diet
(?incorrect diagnosis)
– Gluten free diet commenced before
serology/biopsy – patient unwilling to
challenge – negative HLA excludes CD
– At risk groups but not all (type 1 DM,
autoimmune thyroid or liver disease,
Down’s, Turner’s and William’s
syndrome
– Family members of individuals with
confirmed CD (affects 10% FDR)- may
justify biopsy even if sero-negative.
Identifies patients for screening 1-3 yr?
Abdominal pain, rectal bleeding, diarrhoea and
calprotectin
• 14 yr old boy with 4 mo
rectal bleeding, on toilet
paper
• FH of UC
• Lots of anxiety in family
• DDX
– IBD, POLYPS, FISSURE
Joshi Ann Clin Biochem 2010
Davidson Ann Clin Biochem 2016
Duman Am J Emerg Med 2015
Wikipedia 2016
Abdominal pain, rectal bleeding, diarrhoea and
calprotectin • Calprotectin (no MBS item)
– Soluble protein – 60% of soluble
protein content of neutrophil
cytoplasm
– Bacteriostatic and fungistatic
(sequesters Mg and Zn)
– Resistant to enzymatic degradation –
measured in faeces
– Increased faecal secretion in
intestinal inflammation
• Inflammatory bowel disease
during treatment and as marker
• Coeliac disease (untreated)
• Allergic colitis (infant)
• NEC, Cystic fibrosis, Colorectal
cancer
• NSAIDS
• Bacterial (but not viral)
gastroenteritis
Joshi Ann Clin Biochem 2010
Davidson Ann Clin Biochem 2016
Duman Am J Emerg Med 2015
Wikipedia 2016
Fiona Davidson, and Robert J Lock Ann Clin Biochem 2016;0004563216639335
Copyright © by Association for Clinical Biochemistry
Normal levels of stool calprotectin vary with age –
increased in young
Fiona Davidson, and Robert J Lock Ann Clin Biochem 2016;0004563216639335
Copyright © by Association for Clinical Biochemistry
Calprotectin higher in infancy
Faecal calprotectin
• Higher values below age 1 yr
• Above age of 1 yr
– Extremely useful to identify
intestinal mucosal inflammation
• In presence of rectal bleeding or
CHRONIC diarrhoea
– Normal excludes IBD
• Useful test but no MBS
rebate at present
• Out of pocket varies $50-
100
Undifferentiated gut symptoms
The take-home messages – The screaming baby and PPI’s
• THEY DON’T WORK
– How to dose with PPI’s
• BEST DOSED BEFORE BREAKFAST
– Abdominal pain, diarrhoea
and lactose intolerance
• PRIMARY AND SECONDARY
LACTASE DEFICIENCY
– Treating Dientamoeba – or not?
• TRY NOT TO
– Coeliac disease, serology and HLA
testing
• HLA DQ2/8 IS A USEFUL NEGATIVE
TEST
– Abdominal pain, rectal bleeding,
diarrhoea and calprotectin
• CALPROTECTIN – A REALLY GOOD
TEST TO IDENTIFY INFLAMMATION